Decline of antibodies in XLA infant: when to start IVIG

Maternal antibody levels in XLA neonates may predict when to start replacement IgG.

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen) 2011-03, Vol.66 (3), p.434-435
Main Authors: Okocha, I. U., Hanson, C. G., Chinen, J., Shearer, W. T.
Format: Article
Language:English
Subjects:
Agammaglobulinemia - diagnosis
Agammaglobulinemia - genetics
Agammaglobulinemia - immunology
Agammaglobulinemia - therapy
Amino Acid Substitution
Codon
Genetic Diseases, X-Linked - diagnosis
Genetic Diseases, X-Linked - genetics
Genetic Diseases, X-Linked - immunology
Genetic Diseases, X-Linked - therapy
Humans
Immunoglobulin G
Immunoglobulin Isotypes - blood
Immunoglobulins
Immunoglobulins, Intravenous - therapeutic use
Immunophenotyping
Infant
Infants
Intravenous administration
IVIG
Loss of maternal antibodies in neonates
Male
Mutation
Neonates
Protein-Tyrosine Kinases - genetics
Treatment Outcome
X‐linked agammaglobulinemia
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Maternal antibody levels in XLA neonates may predict when to start replacement IgG.
ISSN:0105-4538
1398-9995
DOI:10.1111/j.1398-9995.2010.02481.x